Last update:

HIV & AIDS news

Medications

Gilead licenses HIV-prevention drug to generic drugmakers

US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income countries.

HIV & AIDS

'Undetectable' HIV patients could hold key to treatments

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.

HIV & AIDS

S.Africa's HIV research power couple says fight goes on

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

HIV & AIDS

How HIV/AIDS got its name

The Centers for Disease Control and Prevention first used the term "AIDS" on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal ...

HIV & AIDS

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.

HIV & AIDS

Ugandan women's autonomy key to safer sex, researchers say

Ugandan women's ability to negotiate the conditions and timing of sex, such as refusing sex and asking for condom use with their partners, is key to preventing several reproductive health outcomes, say experts from the Brown ...

HIV & AIDS

NIH research network finds many youth have high levels of HIV

(Medical Xpress)—More than 30 percent of young males who had sex with other males and who were subsequently enrolled in a government treatment and research network were found to have high levels of HIV, reported researchers ...

HIV & AIDS

The evolution of drug resistance within a HIV population

Drug resistance mutations in HIV reduce the genetic diversity in the rest of the virus genome when they spread within an infected patient, but they do so to a different extent in different patients. A new study published ...

HIV & AIDS

New program helps reduce HIV-risk in African-American women

A new community program is helping African-American women embrace good health by enabling treatment of substance abuse and mental health problems that increase their risk of HIV infection or spreading the virus.

HIV & AIDS

Focus on undiagnosed HIV

A new study that aims to identify rates of undiagnosed HIV in Australia's gay community will offer free testing across six states and territories, including at Sydney's Gay and Lesbian Mardi Gras.

HIV & AIDS

Study identifies risk factors for non-fatal overdoses

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have identified that injection frequency and taking anti-retroviral therapy for HIV are risk factors for nonfatal drug overdoses ...

HIV & AIDS

Mother-daughter team preaches the gospel of HIV prevention

(HealthDay)—Fortunata Kasege was just 22 years old and several months pregnant when she and her husband came to the United States from Tanzania in 1997. She was hoping to earn a college degree in journalism before returning ...

HIV & AIDS

Big strides in battle against pediatric AIDS

(HealthDay)—The effect that AIDS is having on American kids has improved greatly in recent years, thanks to effective drugs and prevention methods. The same cannot be said, however, for children worldwide.

HIV & AIDS

New anti-HIV drug target identified

University of Minnesota researchers have discovered a first-of-its-kind series of compounds possessing anti-human immunodeficiency virus (HIV) activity. The compounds present a new target for potential HIV drug development ...

HIV & AIDS

Spanish hospital to trial new HIV treatment

Researchers at a Spanish hospital announced Monday they will start trials next year of a therapeutic vaccine for patients who already have HIV, the virus that causes AIDS.